London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I have emailed Dr Parker back, with the following (see below). Now I leave Dr's Parker & Mitchell be, to let them get on with their work.
Overall I feel encouraged that a) Dr Parker gave me such a detailed response. b) provided his explanation as to why there are not regular updates (updates for updates sake). c) whatever is RNS'd - you can take to the bank that it's not ramping.
Elcap
Hi Dr Parker,
Thank you for your candid (and swift) response.
I will leave you to your job.
I appreciate the time you have taken to respond.
I hope all goes brilliantly for SAR and us shareholders over the coming weeks / months, and that we are all sharing in the (what I hope to be) the imminent Success of the company.
It is commendable that you do not believe in “ramping” stock the stock without justification. I too detest ramping for ramping’s sake. However there is a fine line between refusing to “ramp” and failure to promote.
(We do not make the rules of the game, however SAR have chosen to play, and as such, need to play the game to win Including maximizing Shareholders returns).
Good luck. I’m excited about the future of SAR.
Once again, thank you for your time.
Many thanks
thanks elcap for writing and sharing your email .i agree with potnak and ahfam3 and am please by stephen parker and tim's quick and honest response
So the 10 tweets/retweets so far in July by Dr Parker I.r.o MGC Pharmaceuticals isn’t ramping....
To be fair to Mr Parker, he also replied to my email... and referred me to the email he sent to Elcap, which had now been published on this board...
So they do keep tabs on what is said here...
fingers crossed for a good second half to 2020...
Guys, there is a difference between "ramping" and "PR". Sareum are relying on just an RNS every few months and it's not really having the desired impact. AN RNS is just a regulatory news event which should not be confused with PR, which is the general day to day raising of the Sareum profile and this is where they are failing. PR stories and comment in the trade and national media would do wonders for Sareum from an investor and licencing perspective. This would filter through to the share price in a positive way and would reassure investors. PR is not ramping it’s the effective messaging of your business. Most successful plc’s are good at general PR which then creates the interest which in turn leads to deals and then an RNS.
All of the companies in elcaps list released RNS' to say they were working on Covid 'products'. It wasn't PR that made them spike. and they did spike. Lots of investors got spike on almost everyone of them and when the Covid thing dies down, they will be left with big losses. Its easy, with hindsight to say SAR should do this, they should be doing what all the other AIM chancers are doing. Genuine question. What PR could SAR put out that would please you?
Think people forget that SAR area drug development company with 4 early stage commands. From a risk point of view. Everything could still fail. A £17 market cap is probably about right until we get news on 1 or all of them.
Potnak, Genuine answer for you: PR is not just RNS announcements it is the drip drip drip of regular comments and features on a daily/weekly basis about Sareum, its key staff and opinions in trade magazines, national newspapers, tv and online. It's an ongoing programme of creating awareness. Sareum don't do this and they should. Effective PR is particularly useful to small sized businesses. Imagine if Sareum was in The Times today or on Sky News or was commented about in The Lancet or were offering their views on a cure for Covid to Fergus Walsh on BBC TV. Imagine what that would do for the credibility of Sareum not just infront of the investment community but infront of licencing partners, especially if there is a competition to partner Sareum. It will enhance Stephen and Tim's hand in negotiating and help to create hunger for Sareum and its science (Oh and by the way it will help the share price, which most investors would be jolly happy about!). In summary, you either want to put your business in the shop window or you don't. It's as simple as that. Those that do make the most of PR tend to be the winners and those that don't tend to be the laggards.
Do you think Mr Dealmaker of BigPharmaCorp sits and reads his Times in the morning hoping to see if any small AIM biotechs are worth buying. Why would anyone ask SAR about Covid cures when we aren't in the business of Covid cures? I understand your frustrations. I have been here a long time too but I have always found SAR to be straight when telling us what we need to know. If you understand that differently and it doesn't comes true, It isn't SARs doing. Show me where Hemo, NCYT or any of the other do this.
Potnak, in one of your recent posts you state: "All of the companies in elcaps list released RNS' to say they were working on Covid 'products'". That's simply not true. When did PYC release a RNS to that effect? You then go on to contend: "Lots of investors got spike on almost everyone of them and when the Covid thing dies down, they will be left with big losses". What about Sareum? The tweets, the subtle hints that they were somehow in possession of the panacea for all of the Covid-19 ills? It turned out they just wanted to inflate their share price in order to dilute the long-term shareholders once again. This from Sareum on the 28th April this year: "The presentation will provide an update of Sareum's two proprietary TYK2/JAK1 kinase inhibitor programmes, SDC-1801 and SDC-1802, targeting autoimmune diseases and cancers, respectively. Dr Mitchell will also highlight the emerging potential of this mechanism to modulate the severe inflammatory responses and respiratory symptoms arising from coronavirus and other viral infections". Only later did it emerge that they hadn't even applied for government funding, 3 months or so after the outbreak in the UK began! The biggest threat to shareholders of Sareum isn't the science supporting their 4 early stage compounds (or, "commands", as you call them), but the ineptitude of the board of directors and people like you spouting nonsense in the vain hope of persuading shareholders to remain invested, for "fear of missing out" (or FOMO). FOMO is what has kept many of us invested here but I have now realized it's all a mirage. Continue to wait if you like, but I have moved on and can now invest in the many companies that I should have invested in back in March this year (many of which are indeed on Elcap's list and which were on my radar initially but I missed out on, foolishly believing Sareum would deliver on their promises). Enough said, but Potnak, stop deluding yourself and others on this board. You're simply WRONG!
PYC
Dr Jim Millen, CEO said: "In these difficult times, it's great to see that lifescience companies can find creative ways to continue to develop the relationships needed to fight COVID-19, cancer and other diseases where new treatments are desperately needed. We look forward to fully participating in the digital version of this popular conference."
Look when PYC spiked. Look at the comments from that time. 26th of Apr. PYC wouldn't be at the SP they are today if it weren't for them mentioning Covid. It should be illegal, but I guess it isn't.
I'm happy with my investment here. Hope your future investments work out for you.
Oh dear, Potnak, you really are clutching at straws. Dr Millen was merely announcing PYC's BioTrinity conference attendance and presentation. "Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models and its Virtual Tumour™ technology to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to announce that it is participating in the BioTrinity 2020 conference which is being held digitally this week. In lieu of face to face meetings, the Company has made a pre-recorded presentation which is available to all conference attendees, the slides for which can also be found on our website here https://www.physiomics.co.uk/resources/. In addition, the Company will participate in a number of virtual 1-1 meetings with potential clients and collaborators." The RNS continues: 'Dr Jim Millen, CEO said: "In these difficult times, it's great to see that lifescience companies can find creative ways to continue to develop the relationships needed to fight COVID-19, cancer and other diseases where new treatments are desperately needed. We look forward to fully participating in the digital version of this popular conference."' What he was saying was that he was pleased that conferences of this nature were able to continue to happen, if only remotely, despite the Covid-19 pandemic. PYC are focused on "the development of cancer treatment regimens and personalised medicine solutions". No mention of any Covid products in the pipeline, no jumping on that particular bandwagon I'm afraid, but nice try!
Potnak you steering about pyc there is a new contract in offering nothing to do with covid. Pyc is going places as they keep doing deals unlike sareum currently . Pyc will quite easily double in next week or so but sar could x10 in next year or so
Look at the comments on the day that RNS came. It was a cynical way to jump on the bandwagon. Since when does announcing attending a conference double the SP? The word Covid did that. Utar the contract is 5 months work for two people, it's right there in the RNS. How big can it possibly be? Will it spike, probably, will it hold, no.
Good answer Glen, why are you concerned about pyc potnak? Be happy with your investment in sar even though for now it's a pretty disappointing performing share sar will at least double sometime. Dig a little more into pyc and you will see that they are close to where some of the action is reference covid. It's more than just a 5 month contract you'll see
I'm not pre occupied with PYC, glenf brought it up. Must be just a coincidence the the sp doubled on the day the MD mentions Covid in an RNS about a virtual conference. My mistake. Carry on. See you in the morning, I've got beer to drink.
I'm not pre occupied with PYC, glenf brought it up. Must be just a coincidence the the sp doubled on the day the MD mentions Covid in an RNS about a virtual conference. My mistake. Carry on. See you in the morning, I've got beer to drink.